CrossBridge Compliance Revenue and Competitors

Longview, TX USA

Location

N/A

Total Funding

Energy/Oil

Industry

Estimated Revenue & Valuation

  • CrossBridge Compliance's estimated annual revenue is currently $44.5M per year.(i)
  • CrossBridge Compliance's estimated revenue per employee is $269,500

Employee Data

  • CrossBridge Compliance has 165 Employees.(i)
  • CrossBridge Compliance grew their employee count by 19% last year.

CrossBridge Compliance's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$38M14123%N/AN/A
#2
$60.6M2254%N/AN/A
#3
$6.7M343%N/AN/A
#4
$11.2M516%N/AN/A
#5
$18.6M766%N/AN/A
#6
$7.3M3915%N/AN/A
#7
$42.3M15734%N/AN/A
#8
$18.6M764%N/AN/A
#9
$6.9M356%N/AN/A
#10
$5M290%N/AN/A
Add Company

What Is CrossBridge Compliance?

Crossbridge Compliance is a multi-service compliance company with experienced personnel in various industry sectors. We provide compliance services such as OQ, Safety training, Safety Inspection, Railcar Inspection, Pipeline Inspection, Welding Inspection, Auditing, Consulting, Asset Integrity Management, Advanced NDT Services, Conventional NDT, ASNT Level III Services and many more . The industries we serve include Oil and Gas, Rail, Pulp and Paper, Utilities, Chemical/Refining, Aerospace and many others. Let Crossbridge "stand in the gap" by being the bridge for your compliance needs. See more by visiting www.crossbridgecompliance.com

keywords:N/A

N/A

Total Funding

165

Number of Employees

$44.5M

Revenue (est)

19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CrossBridge Compliance News

2022-03-30 - Yescarta® Receives U.S. FDA Approval as First CAR T-cell Therapy for Initial Treatment of Relapsed or Refractory Large B-cell Lymphoma

... facilities that dispense and administer YESCARTA must be enrolled and comply with the REMS requirements and must have on-site,...

2022-03-30 - Bristol Myers Squibb Announces Data from EXPLORER-LTE ...

... excessive myosin-actin cross-bridge formation that results in hypercontractility, left ventricular hypertrophy and reduced compliance.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$49.9M16817%N/A
#2
$40.2M174-97%N/A
#3
$15M1778%N/A
#4
$39M1974%N/A
#5
$15M2014%N/A